VCU研究：减肥药Ozempic可能治疗肝病
VCU study: weight-loss drug Ozempic could treat liver disease
作者： ERIC KOLENICH Richmond Times-Dispatch
Turbocharging Ozempic with another drug could become a “game-changer” for treating liver disease, according to a Virginia Commonwealth University study.
根据弗吉尼亚联邦大学的研究，用另一种药物涡轮增压Ozempic可能成为治疗肝病的“游戏规则改变者”。
Weight loss drugs Ozempic and Wegovy have become blockbuster successes in the past year. Now they could assume a new role, according to research from Virginia Commonwealth University treating liver d… [+6310 chars]
减肥药物Ozempic和Wegovy在过去一年取得了巨大的成功。根据弗吉尼亚联邦大学的研究，现在它们可能承担一个新的角色，用于治疗肝脏疾病……[+6310个字符]
原文链接：Richmond.com